Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21ClN4O3 |
InChIKeyIOHJEWFKBRNJIO-UHFFFAOYSA-N |
CAS Registry2887480-87-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 07 Apr 2023 |